DrugJan 24, 2024
Vasostrict recall — FDA D-0232-2024
Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.
Class IIFDA: OngoingPar Sterile Products LLC
Recall history in this database
Classification mix: Class II: 2.
DrugMay 17, 2017
Buprenorphine HCI Injection, 0.3 mg/mL, 1 mL Single Dose Vial (NDC 42023-179-01) recall — FDA D-0698-2017
Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine…
Class IIFDA: TerminatedPAR Sterile Products LLC
Understanding this recall history
This page summarizes recall records in which the official source identifies Par Sterile Products LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.